Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
11%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
10%
ALSO IN PSIL
PSIL
32
HOLDINGS
42%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus PSIL)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PSIL |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 7.0% | 3.9% | 3.9% |
|
JOHNSON & JOHNSON | 6.7% | 3.7% | 3.7% |
|
NEUROCRINE BIOSCIENCES INC | 1.4% | 4.4% | 1.4% |
 |
ALKERMES PLC | 1.2% | 4.0% | 1.2% |
|
SUPERNUS PHARMACEUTICALS INC | 0.4% | 3.6% | 0.4% |
FTXH Overweight Relative to PSIL
|
ELI LILLY & CO | 7.8% |
|
MERCK & CO. INC. | 7.1% |
|
BRISTOL-MYERS SQUIBB CO | 6.8% |
|
VIATRIS, INC. | 4.0% |
|
BIOGEN IDEC INC | 3.8% |
|
PFIZER INC | 3.5% |
|
GILEAD SCIENCES INC | 3.4% |
|
VERTEX PHARMACEUTICALS INC | 3.3% |
|
AMGEN INC | 3.2% |
|
CARDINAL HEALTH INC | 3.2% |
FTXH Underweight Relative to PSIL
|
RELMADA THERAPEUTICS INC | -9.3% |
|
DEFINIUM THERAPEUTICS INC | -8.7% |
|
NEURONETICS, INC. | -5.7% |
|
BRIGHT MINDS BIO | -5.1% |
|
ALTO NEUROSCIENCE INC | -4.7% |
|
SUPERNUS PHARMACEUTICALS INC | -3.2% |
|
NEUROCRINE BIOSCIENCES INC | -3.0% |
|
ALKERMES PLC | -2.8% |
 |
NUMINUS WELLNESS INC | -0.9% |
|
INDIA GLOBALIZATION CAPITAL, INC. | -0.5% |